(Q42686317)

English

A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients

scientific article published on October 2002

Statements

A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients (English)
Lawrence Chodoff

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit